Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
QuintilesIMS
Colorcon
Farmers Insurance
Healthtrust
Teva
Harvard Business School
Johnson and Johnson
US Army
Chubb

Generated: February 25, 2018

DrugPatentWatch Database Preview

FOUGERA PHARMS Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS, and when can generic versions of FOUGERA PHARMS drugs launch?

FOUGERA PHARMS has one hundred and thirteen approved drugs.

There are four US patents protecting FOUGERA PHARMS drugs.

There are fifty-nine patent family members on FOUGERA PHARMS drugs in twenty-seven countries and thirty-one supplementary protection certificates in twelve countries.

Summary for FOUGERA PHARMS
International Patents:59
US Patents:4
Tradenames:54
Ingredients:46
NDAs:113

Drugs and US Patents for FOUGERA PHARMS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms HYDROCORTISONE hydrocortisone OINTMENT;TOPICAL 080692-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Sign Up ➤ Sign Up
Fougera Pharms Inc GENTAMICIN SULFATE gentamicin sulfate CREAM;TOPICAL 062531-001 Jul 5, 1984 DISCN No No ➤ Sign Up ➤ Sign Up
Fougera Pharms CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; clotrimazole CREAM;TOPICAL 075502-001 Jun 5, 2001 AB RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms CICLOPIROX ciclopirox CREAM;TOPICAL 076435-001 Dec 29, 2004 AB RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 085691-002 Approved Prior to Jan 1, 1982 AT RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms MOMETASONE FUROATE mometasone furoate CREAM;TOPICAL 076171-001 Apr 8, 2005 AB RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms ERYTHROMYCIN erythromycin SOLUTION;TOPICAL 064187-001 Sep 30, 1997 DISCN No No ➤ Sign Up ➤ Sign Up
Fougera Pharms FLUTICASONE PROPIONATE fluticasone propionate CREAM;TOPICAL 076451-001 May 14, 2004 AB RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 085692-002 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Sign Up ➤ Sign Up
Fougera Pharms METRONIDAZOLE metronidazole CREAM;TOPICAL 076408-001 May 28, 2004 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for FOUGERA PHARMS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990 3,721,687 ➤ Sign Up
Fougera Pharms ACLOVATE alclometasone dipropionate CREAM;TOPICAL 018707-001 Dec 14, 1982 4,124,707 ➤ Sign Up
Fougera Pharms TEMOVATE clobetasol propionate CREAM;TOPICAL 019322-001 Dec 27, 1985 3,721,687 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,929,048 ➤ Sign Up
Fougera Pharms TEMOVATE clobetasol propionate OINTMENT;TOPICAL 019323-001 Dec 27, 1985 3,721,687 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,639,738 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,852,002 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,985,850 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,914,322 ➤ Sign Up
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,792,753 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for FOUGERA PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Gel 3% ➤ Subscribe 12/16/2009
➤ Subscribe Lotion 0.05% ➤ Subscribe 7/28/2008

Non-Orange Book US Patents for FOUGERA PHARMS

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,968,973 Method for treating hyperplasia ➤ Sign Up
6,197,808 Methods for treating hyperplasia ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for FOUGERA PHARMS Drugs

Supplementary Protection Certificates for FOUGERA PHARMS Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB10/012 United Kingdom ➤ Sign Up PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
269 Luxembourg ➤ Sign Up PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
00581 Netherlands ➤ Sign Up PRODUCT NAME: DROOG EXTRACT VAN GROENE THEE; NAT. REGISTRATION NO/DATE: RVG 110904 20120917; FIRST REGISTRATION: 73486.00.00 20090831
2012 00040 Denmark ➤ Sign Up PRODUCT NAME: EN BLANDING AF CATECHINER ISOLERET FRA ET EKSTRAKT AF GROEN TE (CAMELLIA SINENSIS (L.) O. KUNTTZE) , HERUNDER (-)-EPIGALLOCATECHINGALLAT; NAT. REG. NO/DATE: 49803 (DK) 20120702; FIRST REG. NO/DATE: DE 73486.00.00 20090831
13/044 Ireland ➤ Sign Up PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
90030-4 Sweden ➤ Sign Up PRODUCT NAME: TORRT EXTRAKT AV CAMELLIA SINENSIS (L.) O. KUNTZE, FOLIUM; NAT. REG. NO/DATE: 47136 20120405; FIRST REG.: DE 73486.00.00 20090831
2012 00040 Denmark ➤ Sign Up
C0024 France ➤ Sign Up PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218
C/GB10/005 United Kingdom ➤ Sign Up PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111
C0014 France ➤ Sign Up PRODUCT NAME: FLUTICASONE FLUORATE; REG. NO/DATE: EU/1/07/434/001 20080111
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Merck
Federal Trade Commission
Teva
Accenture
Boehringer Ingelheim
Cerilliant
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot